Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
The U.S. added 142,000 jobs in August, below expectations. The unemployment rate fell to 4.2%. The cooling job market raises chances for an interest rate cut.
The X and Starlink owner plays a game of chicken with Brazil's Supreme Court. Also: Disney v DirecTV, the future of steel, and that crazy ol' stock market!
Find out what Gen Z is saying about how money equates to happiness from Voya Financial and what they think they need to start saving for retirement. Watch!